Menu

1 / 2

ACADIA Pharmaceuticals Inc. (ACAD) Q1 2026 Earnings Call Transcript

Seeking Alpha·SA Transcripts·6 months ago
#NtaL1t9n
#source#chevron#alpha#research#call
Reading 0:00
15s threshold

ACADIA Pharmaceuticals Inc. ( ACAD ) Q1 2026 Earnings Call May 6, 2026 4:30 PM EDT

Company Participants

Albert Kildani - Senior Vice President of Investor Relations & Corporate Communications

Catherine Owen Adams - CEO & Director

Thomas Garner - Executive VP & Chief Commercial Officer

Elizabeth Thompson - Executive VP and Head of Research & Development

Mark Schneyer - Executive VP & CFO

Conference Call Participants

Tessa Romero - JPMorgan Chase & Co, Research Division

Ashwani Verma - UBS Investment Bank, Research Division

Ritu Baral - TD Cowen, Research Division

Brian Abrahams - RBC Capital Markets, Research Division

Tazeen Ahmad - BofA Securities, Research Division

Marc Goodman - Leerink Partners LLC, Research Division

Jack Allen - Robert W. Baird & Co.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.